These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 14512877)

  • 1. Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome.
    DeLeve LD; Wang X; Kanel GC; Ito Y; Bethea NW; McCuskey MK; Tokes ZA; Tsai J; McCuskey RS
    Hepatology; 2003 Oct; 38(4):900-8. PubMed ID: 14512877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat.
    Wang X; Kanel GC; DeLeve LD
    Hepatology; 2000 Feb; 31(2):428-34. PubMed ID: 10655267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9.
    Nakamura K; Hatano E; Narita M; Miyagawa-Hayashino A; Koyama Y; Nagata H; Iwaisako K; Taura K; Uemoto S
    J Hepatol; 2012 Nov; 57(5):1037-43. PubMed ID: 22796153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome.
    DeLeve LD; Ito Y; Bethea NW; McCuskey MK; Wang X; McCuskey RS
    Am J Physiol Gastrointest Liver Physiol; 2003 Jun; 284(6):G1045-52. PubMed ID: 12584111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic sesamol attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats by inhibiting matrix metalloproteinase-9.
    Periasamy S; Hsu DZ; Chen SY; Yang SS; Chandrasekaran VR; Liu MY
    Cell Biochem Biophys; 2011 Nov; 61(2):327-36. PubMed ID: 21681587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The flavonoid monoHER prevents monocrotaline-induced hepatic sinusoidal injury in rats.
    Ezzat T; van den Broek MA; Davies N; Dejong CH; Bast A; Malagó M; Dhar DK; Olde Damink SW
    J Surg Oncol; 2012 Jul; 106(1):72-8. PubMed ID: 22287334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a reproducible rat model of hepatic veno-occlusive disease.
    DeLeve LD; McCuskey RS; Wang X; Hu L; McCuskey MK; Epstein RB; Kanel GC
    Hepatology; 1999 Jun; 29(6):1779-91. PubMed ID: 10347121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic sesame oil attenuates sinusoidal obstruction syndrome by inhibiting matrix metalloproteinase-9 and oxidative stress.
    Periasamy S; Yang SS; Chen SY; Chang CC; Liu MY
    JPEN J Parenter Enteral Nutr; 2013 Jul; 37(4):529-37. PubMed ID: 22821006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A metabonomic evaluation of the monocrotaline-induced sinusoidal obstruction syndrome (SOS) in rats.
    Conotte R; Colet JM
    Toxicol Appl Pharmacol; 2014 Apr; 276(2):147-56. PubMed ID: 24582690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide donors prevent while the nitric oxide synthase inhibitor L-NAME increases arachidonic acid plus CYP2E1-dependent toxicity.
    Wu D; Cederbaum A
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):282-92. PubMed ID: 16938321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic regeneration is decreased in a rat model of sinusoidal obstruction syndrome.
    Schiffer E; Frossard JL; Rubbia-Brandt L; Mentha G; Pastor CM
    J Surg Oncol; 2009 Jun; 99(7):439-46. PubMed ID: 19353590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regorafenib suppresses sinusoidal obstruction syndrome in rats.
    Okuno M; Hatano E; Nakamura K; Miyagawa-Hayashino A; Kasai Y; Nishio T; Seo S; Taura K; Uemoto S
    J Surg Res; 2015 Feb; 193(2):693-703. PubMed ID: 25266603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteral nutrition affects nitric oxide production in peripheral blood and liver after a postoperative lipopolysaccharide-induced endotoxemia in rats.
    Kolios G; Kotzampassi K; Manousou P; Paramythiotis D; Papanastasiou H; Drygiannakis I; Notas G; Tsagarakis N; Eleftheriadis E; Kouroumalis E
    Nutrition; 2007; 23(7-8):575-81. PubMed ID: 17560081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition.
    Deleve LD; Wang X; Tsai J; Kanel G; Strasberg S; Tokes ZA
    Gastroenterology; 2003 Sep; 125(3):882-90. PubMed ID: 12949732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic oral sesame oil is ineffectual against monocrotaline-induced sinusoidal obstruction syndrome in rats.
    Periasamy S; Chien SP; Liu MY
    JPEN J Parenter Enteral Nutr; 2013 Jan; 37(1):129-33. PubMed ID: 22544841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dai-kenchu-to attenuates rat sinusoidal obstruction syndrome by inhibiting the accumulation of neutrophils in the liver.
    Narita M; Hatano E; Tamaki N; Yamanaka K; Yanagida A; Nagata H; Asechi H; Takada Y; Ikai I; Uemoto S
    J Gastroenterol Hepatol; 2009 Jun; 24(6):1051-7. PubMed ID: 19638085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of endogenous nitric oxide in the heart enhances matrix metalloproteinase-2 release.
    Wang W; Viappiani S; Sawicka J; Schulz R
    Br J Pharmacol; 2005 May; 145(1):43-9. PubMed ID: 15711589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N(G)-nitro-L-arginine methyl ester potentiates anaphylactic venoconstriction in rat perfused livers.
    Shibamoto T; Ishibashi T; Shimo T; Cui S; Takano H; Tsuchida H; Nishio M; Kurata Y
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1073-7. PubMed ID: 17042917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of nitric oxide in the modulation of hepatic microcirculation and tissue oxygenation in an experimental model of hepatic steatosis.
    Ijaz S; Yang W; Winslet MC; Seifalian AM
    Microvasc Res; 2005 Nov; 70(3):129-36. PubMed ID: 16203017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble thrombomodulin attenuates sinusoidal obstruction syndrome in rat through suppression of high mobility group box 1.
    Nakamura K; Hatano E; Miyagawa-Hayashino A; Okuno M; Koyama Y; Narita M; Seo S; Taura K; Uemoto S
    Liver Int; 2014 Nov; 34(10):1473-87. PubMed ID: 24498917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.